The Balance
Top Emerging Pharmaceutical Markets
  • Investing
    • Basics
    • Stocks
    • Real Estate
    • Value Investing
    • View All
  • Credit & Debt
    • Building Credit
    • Credit Card Basics
    • Reducing Debt
    • Reports & Scores
    • View All
  • Retirement Planning
    • Basics
    • 401(k) Plans
    • IRAs
    • Social Security
    • View All
  • Banking & Loans
    • Basics
    • Best Savings Account Rates
    • Getting a Loan
    • Online Banking
    • View All
visit our other sites
Biotech Industry
  • Sales and Marketing
  • Technology
  • Business
  • Buffers and Media
  • Biotech Glossary
    Biotech Industry Sales and Marketing

    Top Emerging Pharmaceutical Markets

    • Share
    • Flip
    • Pin
    • Email
    By Kathlyn Stone
    Updated April 19, 2018
  • 01
    China Pharmaceutical Market

    Eli Lilly and Company opened its first overseas representative office in Shanghai in 1918.
    eli lilly

    China could be the world's second largest drug market, after the United States, by 2015, according to IMS Health data.

    Market Size in 2011: $63.9 billion

    Population: 1.3 billion

    Industry Makeup: Very diverse with more than 3,000 local manufacturers, major multinationals and traditional medicine.

    Branded vs. Generic: Generics represented about 64 percent of the market by value, with over-the-counter drugs representing about 26 percent.

    Distribution: Regional market distribution system utilizing many different distributors.

    Main Customers: Hospitals (56 percent), pharmacies (24 percent), local health centers (20 percent)

    Sources: IMS Health, PharmaVentures, Espicom

  • 02
    Brazil Pharmaceutical Market

    Brazil pharma
    AlexLMX / Getty Images

    Market Size in 2011: $22.7 billion

    Population: 206 million

    Industry Makeup: Multinationals currently dominate Brazil's pharmaceutical market but the country has a rapidly growing local industry led by EMS, Aché, Eurofarma, and Hypermarcas.

    Branded vs. Generic: Branded generics (70 percent) lead the market, followed by over-the-counter (17 percent) and patented (12 percent). Brazil's generic sector is the largest among Latin American nations.

    Distribution: A handful of large companies dominate distribution but there are more than 3,000 wholesalers.

    Main Customers: Pharmacies and retail (71 percent), hospitals (8 percent)

    Estimated growth by 2015: 7 to 12 percent

    Sources: IMS Health, PharmaVentures, Epsicon

  • 03
    Asia Pacific Pharmaceutical Market

    asia pacific pharma
    wxin / Getty Images

    Global pharmas have taken interest in the region following improvements in the regulatory environment, rising incomes, skilled workforces and opportunities for contract manufacturing.

    Market Size in 2011: $18.2 billion

    Population: 464 million combined

    Industry Makeup: GlaxoSmithKline, Pfizer, Sanofi-Aventis, Ranbaxy Laboratories and Takeda Pharmaceutical are active in the region.

    Branded vs. Generic: Vietnam has a strong generic market (90 percent of the total), while Singapore's market is 20 percent of the total. The over-the-counter sector is expanding throughout the region.

    Distribution: Large distributors include Zuellig Pharma

    Main Customers: Varies among countries

    Estimated growth by 2015: 7 to 10 percent

    Sources: IMS Health, PharmaVentures, RNCOS

  • 04
    Russia Pharmaceutical Market

    Russian pharma
    aiqingwang / Getty Images

    Several multinationals increased their investments in the Russian pharma market in 2011 including Novartis, which began construction of a manufacturing facility in St. Petersburg and AstraZeneca which began constructing a new manufacturing plant in the Kaluga region.

    Market Size in 2010: $18.7 billion

    Population: 142 million

    Industry Makeup: Most countries have several multinationals operating within

    Branded vs. Generic: Russia's market has been dominated by locally produced generics but there is a growing demand for more branded generics from multinational companies.

    Distribution: In 2010, the top 10 distributors dominated 90 percent of distribution.

    Main Customers: Hospitals, managed care organizations, state agencies, drug retailers.

    Estimated growth by 2015: 10 to 12 percent

    Sources: Espicom, IMS Health, Russian-American Business, DSM Group

  • 05
    India Pharmaceutical Market

    Dr. from India
    Itsabby94 / Getty Images

    Already a global leader in the generic drug market with 3,500 pharmaceutical manufacturers exporting about $10 billion annually to more than 100 countries, India intends to expand its sales to other emerging markets, the United States and Europe. Dr. Reddy's, one of India's largest generic manufacturers, has already made significant inroads in the U.S. market.

    Contract manufacturing of brand-name prescription drugs and hosting clinical trials for multinationals are other areas of growth within the India pharma market.

    Market Size in 2011: $15.7 billion

    Population: 1.2 billion

    Industry Makeup: Significant exports of generics to developed markets including the U.S. and Europe.

    Branded vs. Generic: Branded generics represent 90 percent of prescription drug sales, over-the-counter drugs represent 16 percent of total value of drugs sold.

    Distribution: India relies on a clearing and forwarding agent(CFA)distribution system. While the number of distributors and retail pharmacies is increasing there are still inefficiencies in distribution, particularly in rural areas.

    Main Customers: Pharmacies (70 percent), hospitals (30 percent)

    Estimated growth by 2015: 12 to 16 percent

    Sources: IMS Health, Epsicon, Company reports

  • 06
    Turkey Pharmaceutical Market

    Turkish Pjarma
    bymuratdeniz / Getty Images

    Turkey has a fast-growing pharmaceutical industry and the largest among Middle East nations. Foreign companies own about 80 percent of the local pharmaceutical manufacturing facilities. In April 2012 Amgen acquired 95.6 percent of shares of Mustafa Nevzat Pharmaceuticals (MN), a privately held Turkish pharmaceutical company for $700 million. Turkey has strict price controls and spends about $50 per capita on pharmaceuticals annually, according to Egon Zehnder International, an industry consultancy.

    Market Size in 2011: $11.6 billion

    Industry Makeup: About 85 local and multinational manufacturers

    Branded vs. Generic: Generics represent about 50 percent of volume and 35 percent of value. Over-the-counter represents 11 percent of the total market.

    Distribution: The top two distributors, Hedef and Selcuk Ecza, own 70 percent of the distribution while regional co-ops have a 15 percent share.

    Main Customers: Divided among pharmacies, hospitals, and clinics

    Estimated growth by 2015: 10 to 14 percent

    Sources: IMS Health, PharmaVentures, Company reports

  • Variety of pills and capsules

    What Are the Top Generic Drug Companies?

  • Artificial intelligence brain in network

    Follow These Top Sites for Cutting-Edge Pharma and Biotech News

  • Pharmacist filling perscription

    What Are The Top Selling Cancer Drugs?

  • Doctor and businessman talking in hospital

    Learn What Marketing Tactics Pharmaceutical Companies Can Legally Use

  • workers in a pharmaceutical lab

    Specialty Pharmaceutical Companies Niche Markets Therapeutic Areas

  • Woman getting her blood pressure taken

    A Look at the Most Prescribed Medicines

  • a man holding a pig

    A List of the Largest Animal Pharmaceutical Companies

  • Woman rubbing hands

    10 Best Selling Biologic Drugs in the United States

  • Close up of doctor with bottle writing prescription

    The Costliest Prescription Drugs in the World

  • Shelves Full of Medications

    How Do Biosimilar Drugs Get Approved?

  • scientist using microscope in lab

    Take a Loot at Ranking of the Top Biotech Countries in the World

  • drug manufacturing

    What Is an Active Pharmaceutical Ingredient in Medication?

  • biomedical engineer inspecting artificial hip joints

    Who Is Responsible for Funding Biomedical Research?

  • Sunset vista of Hong Kong from Victoria Peak

    Which Emerging Markets Are Making an Impression With Investors?

  • botanist examining plants in greenhouse

    Genetically Modified Food Timeline and How We Got Here

  • Stem cells

    Controlling Stem Cells with Nanoparticles

Our Best Money Tips, Delivered
You're in! Thanks for signing up.
There was an error. Please try again.
Facebook Pinterest Twitter Flipboard Linkedin
  • Investing
  • Credit & Debt
  • Retirement Planning
  • Banking & Loans
  • About Us
  • Advertise
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Careers
  • Contact
  • Editorial Guidelines
Also from The Balance Team
The Balance Small Business
The Balance Careers
The Balance is part of the Dotdash publishing family.
  • Lifewire
  • ThoughtCo
  • TripSavvy
  • The Spruce
  • and more